Rodgers & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$583K Sell
2,202
-254
-10% -$67K 0.06% 68
2026
Q2
$624K Buy
2,456
+1,108
+82% +$258K 0.06% 68
2026
Q1
$330K Hold
1,348
– – 0.03% 81
2025
Q4
$279K Buy
1,348
+239
+22% +$47.3K 0.03% 87
2025
Q3
$206K Buy
+1,109
New +$190K 0.02% 102
2022
Q3
– Sell
-1,758
Closed -$312K – 83
2022
Q2
$312K Buy
1,758
+51
+3% +$9.09K 0.05% 68
2022
Q1
$303K Sell
1,707
-111
-6% -$18.9K 0.05% 75
2021
Q4
$311K Buy
1,818
+285
+19% +$46.7K 0.05% 76
2021
Q3
$248K Hold
1,533
– – 0.04% 84
2021
Q2
$253K Buy
1,533
+50
+3% +$8.28K 0.04% 81
2021
Q1
$244K Sell
1,483
-305
-17% -$49.4K 0.04% 81
2020
Q4
$281K Buy
+1,788
New +$264K 0.05% 75

Other funds holding JNJ

Rodgers & Associates's JNJ Position: Q3 2026 in Review

Rodgers & Associates reduced its Johnson & Johnson (JNJ) stake by 10% in Q3 2026, selling an estimated $67K and leaving 2,202 shares worth $583K. The position accounts for 0.06% of the portfolio, ranked #68.

Rodgers & Associates first reported a position in JNJ in Q4 2020 and has held it in 12 quarters since. The position peaked at $624K in Q2 2026. 2,291 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Rodgers & Associates held 2,202 shares of Johnson & Johnson worth $583K as of Q3 2026.
  • Rodgers & Associates sold 254 Johnson & Johnson shares in Q3 2026, an estimated $67K.
  • Johnson & Johnson made up 0.06% of Rodgers & Associates's portfolio in Q3 2026, its #68 holding.
  • Rodgers & Associates first reported a position in Johnson & Johnson in Q4 2020 and has held it in 12 quarters since.
  • Rodgers & Associates's Johnson & Johnson position peaked at $624K in Q2 2026.
  • 2,291 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Rodgers & Associates's 13F filing for Q3 2026, filed 20 Oct 2026.